These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 3837691)

  • 1. Selection of antiarrhythmic drugs based on electrophysiologic studies.
    Prystowsky EN
    Cardiovasc Clin; 1985; 16(1):239-59. PubMed ID: 3837691
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical electrophysiology of ventricular tachycardia.
    Prystowsky EN; Heger JJ; Lloyd EA; Zipes DP
    Cardiol Clin; 1983 May; 1(2):253-73. PubMed ID: 6544638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The value of electrophysiological studies in the treatment of ventricular tachycardias with amiodarone alone or in combination with class-I anti-arrhythmia drugs].
    Bellocci F; Santarelli P; Montenero S; Nobile A; Spampinato A; Nava S; Zecchi P; Manzoli U
    Cardiologia; 1988 Apr; 33(4):399-405. PubMed ID: 3409264
    [No Abstract]   [Full Text] [Related]  

  • 4. The selection of antiarrhythmic regimens by electrophysiologic studies: techniques and results.
    Horowitz LN; Spielman SR; Greenspan AM; Webb CR
    Cardiovasc Clin; 1985; 15(3):187-97. PubMed ID: 2870804
    [No Abstract]   [Full Text] [Related]  

  • 5. Electrophysiologic studies of the ventricle.
    Engel TR; Kowey PR; Wetstein L
    Cardiovasc Clin; 1985; 16(1):83-96. PubMed ID: 3837692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Invasive electrophysiologic study: its role in the pre-excitation syndromes.
    Untereker WJ
    Cardiovasc Clin; 1985; 16(1):97-117. PubMed ID: 3915717
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic efficacy and electrophysiologic actions of amiodarone in patients with life-threatening ventricular arrhythmias: potent suppression of spontaneously occurring tachyarrhythmias versus inconsistent abolition of induced ventricular tachycardia.
    Nademanee K; Hendrickson J; Kannan R; Singh BN
    Am Heart J; 1982 Jun; 103(6):950-9. PubMed ID: 7081035
    [No Abstract]   [Full Text] [Related]  

  • 8. [Value and limitations of electropharmacological tests in the selection of anti-arrhythmic therapy in malignant ventricular tachyarrhythmia].
    Klein H
    Cardiologia; 1985 Jul; 30(7):487-92. PubMed ID: 3834995
    [No Abstract]   [Full Text] [Related]  

  • 9. [Value of a serial electropharmacologic study in survivors of a cardiac arrest secondary to ventricular tachycardia or ventricular fibrillation].
    Raviele A; Di Pede F; Delise P; Piccolo E
    G Ital Cardiol; 1984 Sep; 14(9):644-54. PubMed ID: 6510619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Testing the efficacy of antiarrhythmic drugs.
    Anderson JL; Mason JW
    N Engl J Med; 1986 Aug; 315(6):391-3. PubMed ID: 3736612
    [No Abstract]   [Full Text] [Related]  

  • 11. [Ventricular tachycardia in a healthy child. Electrophysiological study and review of the literature].
    Bermejo J; Ardura J; Gimeno F; Fernández MJ
    An Esp Pediatr; 1983 Aug; 19(2):79-87. PubMed ID: 6660642
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic therapy for survivors of sudden death based on programmed stimulation.
    Roy D; Marchlinski FE; Doherty JU; Buxton AE; Josephson ME
    Cardiovasc Clin; 1985; 15(3):179-85. PubMed ID: 3914364
    [No Abstract]   [Full Text] [Related]  

  • 13. Problems of antiarrhythmic treatment in children.
    Coumel P; Fidelle J
    Cardiologia; 1983 Sep; 28(9):767-82. PubMed ID: 6687332
    [No Abstract]   [Full Text] [Related]  

  • 14. Images in cardiovascular medicine. Fatal bidirectional and polymorphic ventricular tachycardia with terminal depolarization abnormality in a child.
    Sivasubramonian S; Rosenthal E
    Circulation; 2004 Feb; 109(7):938-9. PubMed ID: 14981014
    [No Abstract]   [Full Text] [Related]  

  • 15. Should asymptomatic patients with coronary artery disease and nonsustained ventricular tachycardia be treated with antiarrhythmic drugs?
    Epstein LM; Scheinman MM
    Cardiovasc Clin; 1990; 21(1):79-101; discussion 102-4. PubMed ID: 2199057
    [No Abstract]   [Full Text] [Related]  

  • 16. [Electrophysiological evaluation of the treatment of patients with recurrent ventricular tachycardia].
    Mendoza I; Moleiro F; Castellanos A; Casal H; Arends E; Medina V
    Arch Inst Cardiol Mex; 1982; 52(4):301-11. PubMed ID: 7138133
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracardiac electrophysiologic studies for drug selection in ventricular tachycardia: the need for new approaches based in perturbations of the electrophysiologic matrix.
    Arnsdorf MF
    Circulation; 1987 Apr; 75(4 Pt 2):III137-9. PubMed ID: 3829350
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of amiodarone in the management of patients with cardiac arrest.
    Franks AM; Watterson KS
    J Ark Med Soc; 2000 Dec; 97(6):196-9. PubMed ID: 12876823
    [No Abstract]   [Full Text] [Related]  

  • 19. Management of ventricular arrhythmias.
    Reid PR
    Cardiovasc Clin; 1985; 16(1):279-86. PubMed ID: 3915713
    [No Abstract]   [Full Text] [Related]  

  • 20. Amiodarone therapy for drug-refractory fetal tachycardia.
    Strasburger JF; Cuneo BF; Michon MM; Gotteiner NL; Deal BJ; McGregor SN; Oudijk MA; Meijboom EJ; Feinkind L; Hussey M; Parilla BV
    Circulation; 2004 Jan; 109(3):375-9. PubMed ID: 14732753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.